Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

regulatory

A collection of 57 Posts

Trump Administration Unveils 100% Tariffs on Branded Drugs, Sparking Industry Alarm post image
Regulatory Policy healthcare-policy regulatory pharmaceutical

Trump Administration Unveils 100% Tariffs on Branded Drugs, Sparking Industry Alarm

by Newsdesk
U.S. Announces 100% Tariff on Imported Patented Drugs, Poised to Reshape Global Pharmaceutical Supply Chains post image
Regulatory Policy healthcare-policy regulatory pharmaceutical

U.S. Announces 100% Tariff on Imported Patented Drugs, Poised to Reshape Global Pharmaceutical Supply Chains

by Newsdesk
UK Minister: Higher Drug Prices Essential to Retain Pharma Investment and End Industry Feud post image
Regulatory Policy healthcare-policy drug-pricing regulatory

UK Minister: Higher Drug Prices Essential to Retain Pharma Investment and End Industry Feud

by Newsdesk
Yangtze River Pharma Unveils Positive Phase III Results for Insomnia Drug Fazamorexant, Submits NDA post image
Clinical Trial Results clinical-trials drug-development regulatory

Yangtze River Pharma Unveils Positive Phase III Results for Insomnia Drug Fazamorexant, Submits NDA

by Newsdesk
Senhwa Biosciences' CX-5461 Receives FDA IND Clearance for MYC-Driven Lymphoma Trial, Eyes Pan-Cancer Potential post image
regulatory fda clinical-trials

Senhwa Biosciences' CX-5461 Receives FDA IND Clearance for MYC-Driven Lymphoma Trial, Eyes Pan-Cancer Potential

by Newsdesk
First Covid Pill That Prevents Infection After Exposure Awaits FDA Approval post image
regulatory fda clinical-trials

First Covid Pill That Prevents Infection After Exposure Awaits FDA Approval

by Newsdesk
First Covid Pill That Prevents Infection After Exposure Awaits FDA Approval post image
regulatory fda clinical-trials

First Covid Pill That Prevents Infection After Exposure Awaits FDA Approval

by Newsdesk
BBC xyz post image
pharma-industry business earnings regulatory

BBC xyz

Featured post
by Newsdesk
Clinical trial leads to FDA approval of drug for rare, deadly blood cancer post image
regulatory fda clinical-trials

Clinical trial leads to FDA approval of drug for rare, deadly blood cancer

by Newsdesk
D3 Bio, Inc. Announces FDA Breakthrough Therapy Designation and Orphan Drug Designation for D3S-001 for the Treatment of Patients with KRAS G12C-Mutated Cancers post image
regulatory fda clinical-trials

D3 Bio, Inc. Announces FDA Breakthrough Therapy Designation and Orphan Drug Designation for D3S-001 for the Treatment of Patients with KRAS G12C-Mutated Cancers

by Newsdesk
Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program post image
regulatory fda clinical-trials

Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program

by Newsdesk
FDA Shift In Drug Approvals Halts Trial Of Second Skin Cancer Drug post image
regulatory fda clinical-trials

FDA Shift In Drug Approvals Halts Trial Of Second Skin Cancer Drug

by Newsdesk